Isothermal Amplification Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Isothermal Amplification Market size is projected to experience significant growth from 2019 to 2025.
 

Increasing incidence of chronic diseases will offer lucrative growth to isothermal amplification market growth in the forthcoming years. Diseases including oropharyngeal squamous cell carcinoma (OPSCC) are rapidly increasing. Isothermal amplification is more efficient and faster method than Polymerase Chain reaction (PCR) and immunohistochemistry technique for diagnostic testing of human papilloma virus, making it better preferred option over others. The technology significantly inexpensive and therefore is preferable by scientific experts. Aforementioned factors will cater to rising demand for isothermal amplification, thereby expanding business revenue size.
 

Growing demand for molecular diagnostics will stimulate isothermal amplification market growth over the upcoming years. Rising prevalence of infectious diseases such as sexually transmitted diseases (STDs), Hepatitis B and C, will contribute to rise in the demand for molecular diagnostics. Moreover, technological advancements in molecular diagnostics including transcription mediated amplification, loop mediated isothermal amplification, rolling circle amplification and ligase chain reaction utilized for HBV diagnosis will significantly impel isothermal amplification industry growth during foreseeable future.
 

However, strict regulatory framework and lack of awareness of the technology can pose a threat to market growth in upcoming period.
 

Instruments product segment will contribute to considerable market size owing to growing demand for molecular diagnosis. This demand can be attributed to growing burden of infectious and chronic disease. Large number of product approvals by major industry players will assist increase in number of kits, positively impacting segmental growth. Aforementioned factors should stimulate instruments segment growth over the forecast period.
 

Cancer segment will grow at robust pace over the projected timeframe. Higher incidence rate coupled with increasing mortality due to numerous forms of cancer across the globe contribute to high demand for isothermal amplification instruments. Various technological advancements in isothermal amplification will further widen its application in cancer segment.
 

Reference and central laboratories segment will grow at remarkable pace over the forecast timeframe. Growing investment in R&D in emerging economies will significantly impel research activities in developing countries. In addition, increasing number of chronic diseases coupled with expanding healthcare infrastructure will spur segmental size in upcoming years.
 

U.S. isothermal amplification market will foresee lucrative growth in recent years. Isothermal amplification is increasingly being used as a result of growing burden of cancer, chronic ailments and infections across the U.S. Around half of the Americans have at least one chronic disease. Additionally, continuous innovations and significant healthcare expenditure on R&D should augment U.S. isothermal amplification industry growth in forthcoming period.
 

Prominent industry players involved in global isothermal amplification market share include Becton Dickinson, Alere, Hologic, Qiagen and Thermo Fisher Scientific. Firms are undertaking new product introductions and partnerships to achieve competitive advantage as well as capture significant foothold in the market. For instance, in October 2018, Abbott acquired Alere, thereby expanding company’s product portfolio in diagnostics segment.
 

Isothermal Amplification Market By Product, 2014-2025 (USD Million)

• Instrument
• Reagents

Isothermal Amplification Market By Application, 2014-2025 (USD Million)

• Blood Screening
• Infectious Disease Diagnosis
• Cancer
• Others

Isothermal Amplification Market By End-use, 2014-2025 (USD Million)

• Hospitals
• Reference and Central Laboratories
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Mexico
  • Brazil
• Middle East and Africa
  • South Africa
  • Saudi Arabia

Company Profiles:

• Alere (Abbott)
• Becton Dickinson
• bioMerieux SA
• Eiken Chemical Co. Ltd
• Hologic (Gen-Probe)
• Lucigen
• Meridian Bioscience
• OptiGene
• Qiagen
• Quidel Corporation
• Thermo Fisher Scientific
• Ustar Biotechnologies

What Information does this report contain?